Hong Kong Logistics Stock News

Simcere Pharmaceutical Group (SEHK:2096) has drawn fresh attention after agreeing to fund an exploratory idiopathic pulmonary fibrosis project with Stanford Medicine, securing an option to in-license a first in class molecule with full global rights. See our latest analysis for Simcere Pharmaceutical Group. The Stanford IPF collaboration comes at a time when Simcere Pharmaceutical Group’s shares are trading at HK$9.58, with a 30 day share price return down 9.62% and a year to date share price...

Shareholders might have noticed that HKR International Limited ( HKG:480 ) filed its full-year result this time last...

Earlier in June 2026, RemeGen announced that China’s National Medical Products Administration granted full approval for telitacicept in Sjögren’s disease and conditional approval in IgA nephropathy, both supported by positive Phase 2 and Phase 3 clinical data. These decisions expand telitacicept to five approved autoimmune indications in China, underscoring the clinical breadth of RemeGen’s first-in-class BLyS/APRIL dual-target biologic. We’ll now examine how this broadened telitacicept...

China Medical System Holdings (SEHK:867) drew fresh attention after presenting preclinical data for its INHBE-targeting siRNA drug CMS-D008 at the American Diabetes Association’s 86th Scientific Sessions, highlighting weight loss and muscle preservation in animal models. See our latest analysis for China Medical System Holdings. Despite the CMS-D008 update, China Medical System Holdings’ share price has eased, with a 30-day share price return down 6.73% and a 90-day share price return down...

Frost & Sullivan’s 2026 AI Infrastructure Orchestration Platform White Paper recently named Phancy Group’s Rise vGPU a Tier 1 Leading Platform and ranked its ModelHub offering highest among model management platforms, citing strengths in handling heterogeneous AI infrastructure and improving GPU utilization. This independent recognition underscores Phancy Group’s role in pushing China’s AI ecosystem toward a “compute orchestration” era rather than sheer compute accumulation, highlighting the...

XtalPi Holdings (SEHK:2228) has drawn fresh investor attention after announcing a new R&D alliance with a global biopharmaceutical partner to co-develop an oral small molecule therapy targeting a complex GPCR receptor. See our latest analysis for XtalPi Holdings. XtalPi Holdings' recent R&D alliance arrives after a weak run in the share price, with the 30 day share price return down 16.33% and the year to date share price return down 33.83%, even as the 1 year total shareholder return is...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Fresh U.S. tariff proposals of up to 12.5% on imports from 60 economies are reshaping the risk profile for globally exposed stocks, especially those tied to complex cross border supply chains. With partial exemptions for electronics and AI related products, some areas may find a softer landing while others face higher costs and potential pressure on margins. This article focuses on three stocks that appear negatively exposed to the latest trade policy headlines and explains how these tariff...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

It looks like TCL Electronics Holdings Limited ( HKG:1070 ) is about to go ex-dividend in the next 4 days. The...

BYD (SEHK:1211) has received over 150,000 pre orders for its new flagship Great Tang electric SUV. The company is preparing to launch the Great Tang in Europe alongside increased investment in European manufacturing and R&D. These moves raise questions about BYD's ability to scale production and support overseas growth while meeting international demand. BYD enters this phase with its share price at HK$80.85, after the stock declined 6.6% over the past week and 10.4% over the past month...

RemeGen (SEHK:9995) is back in focus after China’s National Medical Products Administration approved new indications for its autoimmune drug Telitacicept in Sjögren’s disease and conditionally in IgA nephropathy, expanding its treated patient pools. See our latest analysis for RemeGen. At a latest share price of HK$68.5, RemeGen’s 1 day share price return of 1.63% follows a 30 day share price decline of 19.32%. Its 1 year total shareholder return of 37.27% and 3 year total shareholder return...

A unit of Kingboard Holdings recently moved to raise about US$1.50 billion through a block trade of shares in Kingboard Laminates, adjusting its financing mix and ownership structure in the process. This fundraising comes as Kingboard Laminates benefits from very strong AI server demand for high-grade laminates and copper foil, where tight supply has turned into concrete order pressure. We will now examine how this large capital raise, set against constrained AI server material supply,...

Akeso (SEHK:9926) is back in focus after presenting Phase II data for its anti CD47 antibody ligufalimab in acute myeloid leukemia at the 2026 European Hematology Association Congress, highlighting survival and response outcomes versus standard therapy. See our latest analysis for Akeso. Akeso's HK$87.55 share price has seen a 4.35% 1 day gain but is still down 22.38% over 30 days and 24.26% over 90 days. The 3 year total shareholder return of 152.67% contrasts with a 4.89% decline over the...

Hong Kong is preparing to launch trading of Chinese treasury futures in offshore yuan on August 3, 2026, opening another channel for investors who care about currency risk, fixed income exposure, and deeper access to China’s markets. As yuan denominated products expand and hedging tools improve, some Hong Kong financial stocks could see stronger trading flows or more client demand, while others may see little direct benefit. This article walks through three Hong Kong Financials and Exchange...

As the Asian markets navigate a complex landscape shaped by global economic shifts and regional developments, investors are increasingly looking for opportunities that can offer growth potential. Penny stocks, often representing smaller or emerging companies, continue to attract attention due to their affordability and potential for significant returns. Despite being an older term, penny stocks remain relevant as they can provide value when backed by strong financial health and solid...

It looks like Boyaa Interactive International Limited ( HKG:434 ) is about to go ex-dividend in the next four days...

The recent price decline of 16% in China High Speed Transmission Equipment Group Co., Ltd.'s ( HKG:658 ) stock may have...

Some IPE Group Limited ( HKG:929 ) shareholders may be a little concerned to see that insider Siu On Chui recently sold...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see COSCO...

The launch of Mainland government bond futures in Hong Kong is turning attention toward stocks tied to renminbi assets and cross-border capital flows. With new tools for managing RMB bond risk offshore, more global investors may start looking more closely at how they gain exposure to Chinese fixed income and related services. For readers, this creates a focused opportunity to reassess which Hong Kong stocks look better positioned as RMB activity grows. This article highlights 3 stocks from...

Hong Kong’s decision to launch trading in Chinese government bond futures has put fresh attention on stocks tied to the city’s financial plumbing, from brokers to exchange operators. For investors watching how new yuan products might shape liquidity, risk management and global access to China’s bond market, this is a moment to reassess which Hong Kong financials appear best placed and which might warrant more caution. This article highlights three stocks from our Hong Kong Financials and...

Hong Kong’s plan to launch offshore yuan treasury futures in August puts the spotlight firmly on Hong Kong and China financial stocks that sit closest to the cross-border bond and currency markets. For investors, this shift in yuan trading and hedging tools could change how capital flows through banks, asset managers, and exchanges linked to the region. This article highlights 3 stocks from the screener that appear particularly exposed to the news, with the potential to be positively...